W. Jonat

276 papers receiving 12.4k citations

W. Jonat's Hit Papers

Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial 2017 · 460 citations
4600+9+18Years since publication5001k1.5k

Peers

W. Jonat
Comparison fields: 5 of 146
  • Cancer Research 5.6k
  • Oncology 2.3k
  • Genetics 2.1k
  • Reproductive Medicine 719
  • Pulmonary and Respiratory Medicine 1.6k
Replace Christian Fridolin Singer with:
Christian Fridolin Singer Austria
Marion Kiechle Germany
R. Kreienberg Germany
Brigitte Kathrin Rack Germany
Prudence A. Francis Australia
Herve R. Bonnefoi France
Virginia Kaklamani United States
Stefan Paul Aebi Switzerland
J. Michael Dixon United Kingdom
Salomon Marcello Stemmer Israel
W. Jonat relative to Christian Fridolin Singer Austria Christian Fridolin Singer's profile →
Citations per field
00.5×1.5×
Christian Fridolin Singer · 1×
Citations per year

Countries citing papers authored by W. Jonat

Since Specialization
Citations

This map shows the geographic impact of W. Jonat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Jonat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Jonat more than expected).

Fields of papers citing papers by W. Jonat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Jonat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Jonat. The network helps show where W. Jonat may publish in the future.

Co-authors

The 25 scholars most cited alongside W. Jonat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with W. Jonat Line = papers co-authored together W. Jonat links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 302 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
Hit paper breakdown →
19981908
2 2005714
3 2006598
4
Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor–Positive Breast Cancer
Hit paper breakdown →
2009544
5
Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Hit paper breakdown →
2017460
6 2007372
7
Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: results of a survival update based on a combined analysis of data from two mature phase III trials. Arimidex Study Group.
1998364
8 1996336
9 2002264
10 1996218
11 2007215
12 2003206
13 1993189
14 2006182
15 2004165
16 1998155
17 2015151
18
Expression of the tumor suppressor gene Maspin in human pancreatic cancers.
2001146
19 1998142
20 2005138

About W. Jonat

W. Jonat is a scholar working on Cancer Research, Obstetrics and Gynecology, Reproductive Medicine, Genetics and Oncology, having authored 302 papers that have together received 13.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (118 papers), Estrogen and related hormone effects (31 papers), Advanced Breast Cancer Therapies (27 papers), Ovarian cancer diagnosis and treatment (19 papers), Breast Lesions and Carcinomas (16 papers), Prenatal Screening and Diagnostics (13 papers), Endometrial and Cervical Cancer Treatments (11 papers) and Uterine Myomas and Treatments (10 papers). The work is most often cited by research in Cancer Research (5.6k citations), Oncology (2.3k citations), Genetics (2.1k citations), Reproductive Medicine (719 citations) and Pulmonary and Respiratory Medicine (1.6k citations). W. Jonat has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Wolfgang EIERMANN, Manfred Kaufmann, Christoph Mundhenke, Anthony Howell, Nicolaì Maass, Norbert Arnold, CARL P. BLOMQVIST, Michael Gnant, Aman U. Buzdar and Liselotte Mettler. Their work appears in journals such as European Journal of Cancer, Archives of Gynecology and Obstetrics, Journal of Clinical Oncology, Journal of Cancer Research and Clinical Oncology and Fertility and Sterility.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact